Santen Inc Home Page


	Annual Report

	Santen Brief History

This is an exciting time for Santen. Inspired by the outstanding success of our innovative ophthalmic products, we’re moving full steam ahead with a renewed emphasis on discovery and development of new products that will make a real difference in eye care.

What’s New
May, 2010 Napa, CA	Santen Inc. Appoints Vice President of Clinical Affairs [pdf:78KB]
May, 2010 Osaka, Japan	Clinical Data, Inc. Licenses Adenosine A_2A Agonist to Santen for Development of Ophthalmic Treatments [pdf:144KB]
April, 2010 Osaka, Japan	Santen and Inspire Announce Approval of DIQUAS^TM for Dry Eye Treatment in Japan [pdf:184KB]
Mar, 2010 Osaka, Japan	Santen Ltd. Announces Change In Management Structure For U.S. Subsidiary Organization [pdf:20KB]

	Santen Inc. USA News	News list
	Santen Pharmaceutical Co., Ltd. Global News	News list

What’s New